AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma treatment Fasenra.

Asthma doctors say the move will put their patients at risk of life-threatening reactions when they take the drugs at home. The provider says the change will make the treatments more convenient and ...

People with severe asthma insured by BlueCross BlueShield of Illinois may soon face a new hurdle in accessing a treatment ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

AstraZeneca Stock Performance Shares of AstraZeneca stock opened at $76.32 on Thursday. The company has a 50 day moving average price of $72.47 and a 200 day moving average price of $72.16. The ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a new study conducted by researchers at King's College London (KCL ...

Your airways become swollen during an acute exacerbation of asthma. Your muscles contract and your bronchial tubes narrow. Breathing can become more difficult. When asthma symptoms flare up and ...

Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It can cause symptoms such as shortness of breath, coughing, or wheezing. Asthma is a long ...

At close: 5:29:52 PM GMT+1 Loading Chart for AZN.ST ...

After hours: March 21 at 7:45:21 p.m. EDT Loading Chart for AZN ...

After hours: 21 March at 7:45:21 pm GMT-4 Loading Chart for AZN ...